Aegerion Pharmaceuticals to Announce Fourth-Quarter and Full-Year 2013 Financial Results on Wednesday, February 26

        Print
| Source: Aegerion Pharmaceuticals, Inc.

CAMBRIDGE, Mass., Feb. 13, 2014 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, announced that the Company will host a conference call and live audio webcast at 8:30 a.m. EST on Wednesday, February 26, 2014, to provide a business update, and to discuss its fourth-quarter and full-year 2013 financial and operational results.

To listen to the live webcast of the call, please visit the "Investors" section of the Company's website at www.aegerion.com. Individuals may also participate in the call via telephone by dialing (866) 516-3002 or (760) 298-5082. Interested parties unable to join the live call may access an archived version of the webcast on Aegerion's website for up to 30 days following the call.

About Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals is a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases. For more information about the company, please visit www.aegerion.com.

Aegerion Pharmaceuticals, Inc.
Amanda Murphy, Manager, IR
857-242-5024